v3.26.1
Stock Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Company Compensation Expense for the ESOP At June 30, 2026 and December 31, 2025, total unearned compensation for the ESOP was $3.6 million and $3.7 million, respectively.

 

 

June 30, 2026

 

 

December 31,
2025

 

Shares held by the ESOP include the following:

 

 

 

 

 

 

Allocated

 

 

85,926

 

 

 

70,572

 

Committed to be allocated

 

 

7,678

 

 

 

15,354

 

Unallocated

 

 

330,111

 

 

 

337,789

 

Total

 

 

423,715

 

 

 

423,715

 

Summary of Non-vested Stock Options Outstanding

A summary of non-vested stock options outstanding as of June 30, 2026 and December 31, 2025 and changes during the periods then ended is presented below:

 

June 30, 2026

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (in Years)

 

 

Aggregate Intrinsic Value

 

Stock options:

 

 

 

 

 

 

 

 

 

(In Thousands)

 

Outstanding at beginning of period

 

526,894

 

 

$

8.72

 

 

 

7.9

 

 

$

2,360

 

     Granted

 

 

 

 

 

 

 

 

 

 

 

     Exercised

 

(917

)

 

 

9.29

 

 

 

 

 

 

 

 Forfeited

 

(14,000

)

 

 

9.29

 

 

 

 

 

 

 

Outstanding at end of period

 

511,977

 

 

$

8.72

 

 

 

7.4

 

 

$

4,167

 

 

 

 

 

 

 

 

 

 

 

 

 

 Fully vested and expected to vest

 

344,144

 

 

$

8.72

 

 

 

6.8

 

 

$

2,801

 

 

 

 

 

 

 

 

 

 

 

 

 

 Exercisable at end of period

 

344,144

 

 

$

8.72

 

 

 

6.8

 

 

$

2,801

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2025

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (in Years)

 

 

Aggregate Intrinsic Value

 

Stock options:

 

 

 

 

 

 

 

 

 

(In Thousands)

 

Outstanding at beginning of year

 

529,644

 

 

$

8.72

 

 

 

8.9

 

 

$

684

 

     Granted

 

 

 

 

 

 

 

 

 

 

 

     Exercised

 

 

 

 

 

 

 

 

 

 

 

 Forfeited

 

(2,750

)

 

 

9.29

 

 

 

 

 

 

 

Outstanding at end of year

 

526,894

 

 

$

8.72

 

 

 

7.9

 

 

$

2,360

 

 

 

 

 

 

 

 

 

 

 

 

 

 Fully vested and expected to vest

 

255,346

 

 

$

8.72

 

 

 

7.4

 

 

$

1,144

 

 

 

 

 

 

 

 

 

 

 

 

 

 Exercisable at end of year

 

255,346

 

 

$

8.72

 

 

 

7.4

 

 

$

1,144

 

Summary of Non-vested Restricted Shares Outstanding

A summary of non-vested restricted shares outstanding as of June 30, 2026 and December 31, 2025 and changes during the periods then ended is presented below:

 

Three and Six Months Ended June 30, 2026

 

 

Number of Shares

 

 

Weighted Average Grant Value

 

Restricted stock:

 

 

 

 

 

Non-vested at beginning of period

 

74,800

 

 

$

9.29

 

     Granted

 

 

 

 

 

     Vested

 

 

 

 

 

 Forfeited

 

(3,333

)

 

 

9.29

 

Non-vested at end of period

 

71,467

 

 

$

9.29

 

 

 

 

 

 

 

 

Year Ended December 31, 2025

 

Restricted stock:

 

 

 

 

 

Non-vested at beginning of year

 

112,200

 

 

$

9.29

 

     Granted

 

 

 

 

 

     Vested

 

(37,400

)

 

 

9.29

 

 Forfeited

 

 

 

 

 

Non-vested at end of year

 

74,800

 

 

$

9.29